Advanced Oncotherapy Current EV significantly below cumulative investment to date (VIDEO)

Advanced Oncotherapy (LON:AVO) is the topic of conversation when Dr Martin Hall, Analyst at Hardman & Co joins DirectorsTalk.

Martin updates us on some of the recent developments at the company, explains why the share price is languishing, the demand for the project, shares his thoughts on the success of LIGHT and the company valuation.

Advanced Oncotherapy plc is a UK-based company focused on delivering a cost-effective proton-based radiotherapy solution called LIGHT. Based on ground-breaking technology developed and tested at world renowned CERN in Switzerland, the LIGHT system delivers an integrated proton radiotherapy system to treat cancer.

Find more news, interviews, share price & company profile here for:

    You can also listen to our interviews on: 

    Share this interview

    Want to share this interview on a forum? Use this forum friendly link: https://1lo.co/BR0Kc
    Twitter
    LinkedIn
    Facebook
    Email
    WhatsApp
    Advanced Oncotherapy Current EV significantly below cumulative investment to date (VIDEO)

    Other Interviews

    More News

    Ask your questions

    Do you have questions you’d like to ask this company, get in touch and we’ll ask them for you.   

    I have questions